Literature DB >> 16198956

Intrathoracic rhabdoid carcinoma: a clinicopathological, immunohistochemical, and ultrastructural study of 6 cases.

Giovanni Falconieri1, Cesar A Moran, Stefano Pizzolitto, Andreja Zidar, Vito Angione, Paul E Wakely.   

Abstract

We evaluated the clinicopathological spectrum of intrathoracic rhabdoid carcinoma, including its immunophenotype and ultrastructural features. Our series included 6 cases arising from the lung (4 cases) and the anterior mediastinum (2 cases). The patients were 4 men and 1 woman aged between 40 and 63 years (median, 53 years). Microscopically, all of the lesions were composed of loosely cohesive, large, atypical polygonal cells, with glassy cytoplasms and eccentric nuclei. Chromatin texture was finely granular or open. On immunohistochemical stain, the neoplastic cells were positive for vimentin in all cases, positive for vimentin, keratins and/or epithelial membrane antigen in all cases, and negative for other antigens. In 1 case, neoplastic cells were also positive for CD34. Electron microscopic study showed prominent perinuclear whorls of densely packed intermediate filaments or mitochondria. All patients were treated with combined chemotherapy and radiotherapy. One patient died 8 months after the diagnosis was made. Of the remaining patients, 3 are alive with evidence of disease progression, including brain metastases. We concluded that rhabdoid neoplasms arising in the thoracic cavity are aggressive tumors of epithelial lineage and should be categorized as true "rhabdoid carcinomas" instead of being ambiguously designated as "intrathoracic rhabdoid tumors" or "carcinomas with rhabdoid phenotype."

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198956     DOI: 10.1016/j.anndiagpath.2005.07.003

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  6 in total

Review 1.  [Lung cancer. Developments, concepts and preview of the new WHO classification].

Authors:  I Petersen; A Warth
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Gastric adenocarcinoma with rhabdoid morphology.

Authors:  Kohei Shomori; Kenji Sugamura; Kaori Adachi; Tatsushi Shiomi; Eiji Nanba; Hisao Ito
Journal:  Gastric Cancer       Date:  2011-03-17       Impact factor: 7.370

Review 3.  Lung cancer: developments, concepts, and specific aspects of the new WHO classification.

Authors:  Iver Petersen; Arne Warth
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-22       Impact factor: 4.553

4.  Malignant Rhabdoid Tumor of the Mediastinum: A Case Report and Literature Review.

Authors:  Wing Ki Ng; Boon Ping Toe; Hin Yue Lau
Journal:  J Clin Imaging Sci       Date:  2019-03-28

5.  Rhabdoid carcinoma of the rectum.

Authors:  Narimantas Evaldas Samalavicius; Rokas Stulpinas; Valdas Gasilionis; Edita Baltruskeviciene; Eduardas Aleknavicius; Ugnius Mickys
Journal:  Ann Coloproctol       Date:  2013-12-31

6.  SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.

Authors:  Natasha Rekhtman; Joseph Montecalvo; Jason C Chang; Deepu Alex; Ryan N Ptashkin; Ni Ai; Jennifer L Sauter; Brie Kezlarian; Achim Jungbluth; Patrice Desmeules; Amanda Beras; Justin A Bishop; Andrew J Plodkowski; Mrinal M Gounder; Adam J Schoenfeld; Azadeh Namakydoust; Bob T Li; Charles M Rudin; Gregory J Riely; David R Jones; Marc Ladanyi; William D Travis
Journal:  J Thorac Oncol       Date:  2019-11-18       Impact factor: 15.609

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.